Objetivo The host laboratory has recently discovered that human RNaseP specifically cleaves the hepatitis C virus RNA in vitro. We will assess whether RNaseP plays any role in the virus life cycle and whether such cleavage may be postulated as a therapeutic target. Ámbito científico natural sciencesbiological sciencesmicrobiologyvirologymedical and health scienceshealth sciencesinfectious diseasesnatural sciencesbiological sciencesgeneticsRNA Programa(s) FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002 Tema(s) 1.1.1.-2. - Key action Control of Infectious Diseases Convocatoria de propuestas Data not available Régimen de financiación RGI - Research grants (individual fellowships) Coordinador N/A Aportación de la UE Sin datos Dirección Ver en el mapa Coste total Sin datos